The future of bariatric surgery research: A worldwide mapping of registered trials.


Journal

Obesity reviews : an official journal of the International Association for the Study of Obesity
ISSN: 1467-789X
Titre abrégé: Obes Rev
Pays: England
ID NLM: 100897395

Informations de publication

Date de publication:
06 2022
Historique:
revised: 16 12 2021
received: 27 10 2021
accepted: 16 12 2021
pubmed: 18 2 2022
medline: 11 5 2022
entrez: 17 2 2022
Statut: ppublish

Résumé

The bariatric surgery (BS) research landscape is a continuous evolving. Since the first described procedure, numerous different techniques have been developed by surgical teams. In this context, we conducted a systematic mapping of upcoming randomized controlled trials (RCTs) in BS for people with obesity. In June 2021, we performed a systematic review of RCTs evaluating BS versus another surgical procedure or versus a medical control group, through a search in ClinicalTrials.gov. There was no restriction on outcomes for study selection. A total of 62 RCTs were included, totaling 10,800 potential individuals to be included, with planned Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy surgeries the most common. The median number of patients planned to be enrolled is 78 (IQR: 50-143). Mean follow-up time is 12 months in 55% of trials and 4 years or more in 23%. The most frequent (81% of RCTs) outcomes to be investigated are obesity-related diseases with the study of type 2 diabetes, followed by weight loss, quality of life, and surgical complications. The rising number of BS procedures around the world has been followed by a subsequent surge in BS research. An increase in interest is observed in outcomes such as obesity-related diseases, intermediate metabolic markers, quality of life, and body composition.

Identifiants

pubmed: 35174619
doi: 10.1111/obr.13433
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13433

Informations de copyright

© 2022 World Obesity Federation.

Références

Swinburn BA, Kraak VI, Allender S, et al. The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report. Lancet. 2019;393(10173):791-846. doi:10.1016/S0140-6736(18)32822-8
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. doi:10.1038/s41574-019-0176-8
Yanovski JA. Trends in underweight and obesity-scale of the problem. Nat Rev Endocrinol. 2018;14(1):5-6. doi:10.1038/nrendo.2017.157
Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879-887. doi:10.1001/jama.2020.12567
Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377(12):1143-1155. doi:10.1056/NEJMoa1700459
Syn NL, Cummings DE, Wang L, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397(10287):1830-1841. doi:10.1016/S0140-6736(21)00591-2
Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018;79:97-107. doi:10.1016/j.metabol.2017.12.010
Ozsoy Z, Demir E. The evolution of bariatric surgery publications and global productivity: a bibliometric analysis. Obes Surg. 2018;28(4):1117-1129. doi:10.1007/s11695-017-2982-1
Ozsoy Z, Demir E. Which bariatric procedure is the most popular in the world? A bibliometric comparison. Obes Surg. 2018;28(8):2339-2352. doi:10.1007/s11695-018-3163-6
Poghosyan T, Caille C, Moszkowicz D, Hanachi M, Carette C, Bouillot JL. Roux-en-Y gastric bypass for the treatment of severe complications after omega-loop gastric bypass. Surg Obes Relat Dis. 2017;13(6):988-994. doi:10.1016/j.soard.2016.12.003
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822-1832. doi:10.1007/s11695-015-1657-z
Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783-3794. doi:10.1007/s11695-018-3450-2
Angrisani L, Santonicola A, Iovino P, Ramos A, Shikora S, Kow L. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2021;31(5):1937-1948. doi:10.1007/s11695-020-05207-7
di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020;34(6):2332-2358. doi:10.1007/s00464-020-07555-y
de Angelis CD, Drazen JM, Frizelle FA, et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2005;143(2):146-148. doi:10.7326/0003-4819-143-2-200507190-00016
Komenda M, Schwarz D, Švancara J, Vaitsis C, Nabil Zary N, Dušek L. Practical use of medical terminology in curriculum mapping. Comput Biol Med. 2015;63:74-82. doi:10.1016/j.compbiomed.2015.05.006
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. doi:10.1016/j.ijsu.2021.105906
Dabi Y, Darrigues L, Katsahian S, Azoulay D, de Antonio M, Lazzati A. Publication trends in bariatric surgery: a bibliometric study. Obes Surg. 2016;26(11):2691-2699. doi:10.1007/s11695-016-2160-x
Rives-Lange C, Rassy N, Carette C, Phan A, Barsamian C, Thereaux J, et al. Seventy years of bariatric surgery: A systematic mapping review of randomized controlled trials. Obes Rev [Internet]. 2022 Jan 17 [cited 2022 Feb 15]; Available from: https://onlinelibrary.wiley.com/doi/10.1111/obr.13420
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
Voineskos SH, Coroneos CJ, Ziolkowski NI, et al. A systematic review of surgical randomized controlled trials: Part 2. Funding source, conflict of interest, and sample size in plastic surgery. Plast Reconstr Surg. 2016;137(2):453e-461e. doi:10.1097/01.prs.0000475767.61031.d1
Rubino F. From bariatric to metabolic surgery: definition of a new discipline and implications for clinical practice. Curr Atheroscler Rep. 2013;15(12):369. doi:10.1007/s11883-013-0369-x
Cederholm T, Jensen GT, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition-a consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019;10(1):207-217. doi:10.1002/jcsm.12383
Nuzzo A, Czernichow S, Hertig A, et al. Prevention and treatment of nutritional complications after bariatric surgery. Lancet Gastroenterol Hepatol. 2021;6(3):238-251. doi:10.1016/S2468-1253(20)30331-9
Dawes AJ, Maggard-Gibbons M, Maher AR, et al. Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis. JAMA. 2016;315(2):150-163. doi:10.1001/jama.2015.18118

Auteurs

Claire Rives-Lange (C)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.
University of Paris, Paris, France.
INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Paris, France.

Tigran Poghosyan (T)

University of Paris, Paris, France.
Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Digestive Surgery, European Hospital Georges Pompidou, Paris, France.

Nathalie Rassy (N)

Department of Cancer Medicine, Gustave Roussy, Villejuif, France.

Claire Carette (C)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.
University of Paris, Paris, France.
Clinical Investigation Center 1418, Assistance Publique-Hôpitaux de Paris (AP-HP), European Hospital Georges Pompidou, Paris, France.

Aurelie Phan (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.

Marc Goeau-Brissonnière (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.

Flore de Castelbajac (F)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.

Amel Merazka (A)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.

Sebastien Czernichow (S)

Assistance Publique-Hôpitaux de Paris (AP-HP), Nutrition Department, European Hospital Georges Pompidou, Paris, France.
University of Paris, Paris, France.
INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), METHODS team, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH